|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 31, 2017 ) Dermatology drugs market include medications that are used for the treatment of skin conditions such as dermatitis (including eczema), rosacea, hyperhidrosis, androgenic alopecia, onychomycosis, hair loss, acne, immune disorders (including psoriasis), microbial infections (bacterial, fungal, and viral), vascular and pigmented lesion removal, common warts, seborrheic keratosis, and other skin diseases.
These drugs can be sold as OTC as well as prescription drugs. Some of the major OTC drugs include Differin, Lamisil, Monistat, and Abreva. Some of the major dermatology prescription drugs include Humira, guselkumab, Abilify, Sovaldi, Harvoni, and Nexium.
For more information about this report at http://www.reportsweb.com/dermatology-drugs-market-global-report-2017
The global dermatology drugs market was estimated to be around $31 billion as of 2016. The dermatology drugs market made up around 3% of the overall pharmaceuticals market in 2016. The dermatology drugs market was the thirteenth largest market in the global pharmaceutical market in 2016.
Increase in Mergers and Acquisitions Activity
The market has witnessed multiple strategic initiatives in the recent years. Top companies in the dermatology drugs market strategically acquired start-ups and mid-sized companies to broaden products and services. For instance, LEO Pharma, a Denmark-based company acquired the global dermatology business of Astellas Pharma for $725 million. This deal allows LEO to increase its product portfolio with Astellas Pharma's dermatology products include Protopic, Locoid, Locobase and Zineryt. Also Piramal Enterprises Ltd, an Indian based company acquired over-the-counter dermatology brand Caladryl in India from Valeant Pharmaceuticals Inc. Through this acquisition Piramal widen its consumer products portfolio in the skin care segment. The process of consolidation in the industry is boosting growth by increasing the marketing and distribution power of dermatology drug companies.
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001890201/sample
Table of Content
1. Dermatology Drugs Market Characteristics
2. Dermatology Drugs Market Size And Growth
3. Pestle Analysis
4. Dermatology Drugs Market Customer Information
5. Dermatology Drugs Market Segmentation
6. Dermatology Drugs Market Regional And Country Analysis
7. Global Dermatology Drugs Market Comparison With Macro Economic Factors
8. Dermatology Drugs Market Comparison With Macro Economic Factors Across Countries
9. Dermatology Drugs Market Comparison With Industry Metrics
10. Asia-Pacific Dermatology Drugs Market
11. Western Europe Dermatology Drugs Market
12. Eastern Europe Dermatology Drugs Market
13. North America Dermatology Drugs Market
14. South America Dermatology Drugs Market
15. Middle East Dermatology Drugs Market
16. Africa Dermatology Drugs Market
17. Dermatology Drugs Market Competitive Landscape
18. Key Mergers And Acquisitions In The Dermatology Drugs Market
19. Market Background: Pharmaceutical Drugs Market
20. Pharmaceuticals Industry Financial Margins
21. Appendix
Companies Mentioned
Antibacterial,
Anti-Fungal,
Anti-Viral
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001890201/buying
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
